Home > D. Systemic pathology > Toxics and drugs > Therapeutics > Targeted therapy > anti-IL-6 drugs

anti-IL-6 drugs

Monday 2 January 2012

Wikipedia

Anti-interleukin-6 agents are a recent class of therapeutics.

Interleukin-6 is relevant to many inflammatory diseases and many cancers. Hence anti-IL-6 agents have been sought.

Types

- tocilizumab (Actemra)
- In clinical trials

  • esilimomab for some cancers
  • CNTO-328
  • ALD-518
  • CNTO-136
  • CPSI-2364[6], CDP6038[7].
  • VX30
  • ARGX-109
  • FE301
    - FM101